This research revealed the activation of GPR30-mediated non-classic estrogen pathway in mast cells in endometriotic lesions with high local estrogen, and the potential mechanism of mast-cells-derived FGF2 in endometriosis-related pain was explored, as shown in Figure 8. The gene discussed is FGF2; the disease is endometriosis.